More importantly, there were few clues about the role of CTSB in glioma-related immune activities, which greatly limits the understanding of the function and mechanism of CTSB in gliomas and restricts the clinical transformation of CTSB-targeted therapy for gliomas. The gene discussed is CTSB; the disease is glioma.